[1] [2] Menstrual irregularities are not listed as a recognised adverse reaction in the Summary of Product Characteristics (SmPC) approved by the Medicines and Healthcare products Regulatory Agency (MHRA), though some women have reported changes to their menstrual cycle while taking this medication
Active Ingredient: semaglutide
For instance, in October 2024, the EMA approved semaglutide (Wegovy) for treating obesity in adolescents aged 1217, expanding its therapeutic reach
However, penicillamine, a copper chelator used in Wilson's Disease, has been reported to, at times, both induce psychosis or reverse psychosis
We'll take it from there with expert guidance, personalized recommendations, and a custom plan made just for you
Where is the least painful injection site for Ozempic